Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Marta, Mir"'
Autor:
Laura Vidal, Miriam Andrés, Marta Mir, Pilar Forns, Sara Sevilla, Bernat Vidal, Estrella Lozoya, Cristina Esteve, Mónica Bravo, Manel Ferrer, Paul R. Eastwood, Richard S. Roberts, Jordi Castro, Elena Gómez, Marta Calbet, Pere Vilaseca, Jacob González, Imma Moreno, Silvia Petit, J. A. Alonso, Maria Antonia Buil
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:5127-5133
The correct positioning and orientation of an hydrogen bond acceptor (HBA) in the tail portion of the biaryl series of CRTh2 antagonists is a requirement for long receptor residence time. The HBA in combination with a small steric substituent in the
Autor:
Cristina Esteve, Jacob González, Pere Vilaseca, Marta Calbet, Imma Moreno, Marta Mir, Richard S. Roberts, Silvia Petit, Elena Gómez, Mónica Bravo, Miriam Zanuy, J. A. Alonso, Manel Ferrer, Sara Sevilla, Laura Vidal, Peter Eichhorn, Miriam Andrés, Paul R. Eastwood, Bernat Vidal
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 24:5123-5126
Extensive structure–activity relationship (SAR) and structure–kinetic relationship (SKR) studies in the bicyclic heteroaromatic series of CRTh2 antagonists led to the identification of several molecules that possessed both excellent binding and c
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P1 direct agonists
Autor:
Gema Tarrasón, Nuria Godessart, Marta Mir, Clara Armengol, Mònica Córdoba, Dolors Vilella, Daniel Casals, Manel López, Victor Segarra, Teresa Doménech, Imma Moreno, M Sabate, Nuria Aguilar, Pedro M. Grima, María Domínguez, Laia Esteban
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:7672-7676
Amido-1,3,4-thiadiazoles have been identified as a novel structural class of potent and selective sphingosine-1-phosphate receptor subtype 1 agonists. Starting from a micromolar HTS hit with the help of an in-house homology model, robust structural
Autor:
Montserrat Miralpeix, Manel López, Marcos Castillo, Montse Erra, Adelina Orellana, Bernat Vidal, Marta Mir, Pilar Forns, Isabel Ramis, M. I. Maldonado, Cristina Carreño
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:5419-5423
A novel class of potent Syk inhibitors has been developed from rational design. Highly potent aminopyridine derivatives bearing a 4-trifluoromethyl-2-pyridyl motif and represented by compound 13b IC50: 0.6 nM were identified. Substitution by a 2-pyra
Autor:
Paul R. Eastwood, Jacob González, Cristina Balagué, Elena Gómez, Francisco Caturla, Josep Aiguadé, Victor G. Matassa, Nuria Aguilar, María Domínguez, Marta Mir, Adelina Orellana
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 21:6253-6257
Crystallographic structural information was used in the design and synthesis of a number of bioisosteric derivatives to replace the amide moiety in a lead series of p38α inhibitors which showed general hydrolytic instability in human liver preparati
Autor:
Pere Vilaseca, Elena Gómez, Mónica Bravo, Jacob González, Jordi Castro, Miriam Andrés, Bernat Vidal, Richard S. Roberts, Marta Mir, Silvia Petit, Maria Antonia Buil, Miriam Zanuy, Cristina Esteve, Marta Calbet, J. A. Alonso, Laura Vidal, Peter Eichhorn, Paul R. Eastwood
Publikováno v:
Bioorganicmedicinal chemistry letters. 24(21)
A knowledge-based design strategy led to the discovery of several new series of potent and orally bioavailable CRTh2 antagonists where a bicyclic heteroaromatic ring serves as the central core. Structure–kinetic relationships (SKR) opened up the po
Discovery of a novel class of zwitterionic, potent, selective and orally active S1P₁ direct agonists
Autor:
Nuria, Aguilar, Marta, Mir, Pedro M, Grima, Manel, López, Victor, Segarra, Laia, Esteban, Imma, Moreno, Nuria, Godessart, Gema, Tarrasón, Teresa, Domenech, Dolors, Vilella, Clara, Armengol, Mònica, Córdoba, Mar, Sabaté, Daniel, Casals, Maria, Domínguez
Publikováno v:
Bioorganicmedicinal chemistry letters. 22(24)
Amido-1,3,4-thiadiazoles have been identified as a novel structural class of potent and selective sphingosine-1-phosphate receptor subtype 1 agonists. Starting from a micromolar HTS hit with the help of an in-house homology model, robust structural-a